Transforming Growth Factor-β1 (TGF-β1) Induces Mouse Precartilaginous Stem Cell Proliferation through TGF-β Receptor II (TGFRII)-Akt-β-Catenin Signaling

International Journal of Molecular Sciences

Volumn 15, Issue 7, 2014, Pages 12665-12676

  Cheng, Li ^a   Zhang, Chengyu ^a   Li, Ding ^a   Zou, Jian ^a   Wang, Junfang ^a  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Chondrogenesis; Precartilaginous stem cells; Proliferation; catenin and signaling; TGF 1

Indexed keywords

BETA CATENIN; PROTEIN KINASE B; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; CYCLIN D1; FGFR3 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MYC PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; GENE SILENCING; GENETIC TRANSCRIPTION; IMMUNOFLUORESCENCE MICROSCOPY; MOUSE; NONHUMAN; PHENOTYPE; PHOSPHORYLATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; ROOM TEMPERATURE; SIGNAL TRANSDUCTION; STEM CELL; WESTERN BLOTTING; ACTIVE TRANSPORT; ANIMAL; C57BL MOUSE; CARTILAGE CELL; CELL CULTURE; CELL NUCLEUS; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BETA CATENIN; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84904480149     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150712665     Document Type: Article

References (43)

1. Tscheudschilsuren, G.; Bosserhoff, A. K.; Schlegel, J.; Vollmer, D.; Anton, A.; Alt, V.; Schnettler, R.; Brandt, J.; Proetzel, G. Regulation of mesenchymal stem cell and chondrocyte differentiation by MIA. Exp. Cell Res. 2006, 312, 63-72.
2. Zhang, S.; Chen, A.; Hu, W.; Li, M.; Liao, H.; Zhu, W.; Song, D.; Guo, F. Immunological purification of rat precartilaginous stem cells and construction of the immortalized cell strain. Arch. Orthop. Trauma Surg. 2008, 128, 1339-1344.
3. Robinson, D.; Hasharoni, A.; Cohen, N.; Yayon, A.; Moskowitz, R. M.; Nevo, Z. Fibroblast growth factor receptor-3 as a marker for precartilaginous stem cells. Clin. Orthop. Relat. Res. 1999, 367, S163-S175.
4. Guo, X.; Chu, X.; Li, W.; Pan, Q.; You, H. Chondrogenic effect of precartilaginous stem cells following NLS-TAT cell penetrating peptide-assisted transfection of eukaryotic hTGFbeta3. J. Cell. Biochem. 2013, 114, 2588-2594.
5. Watabe, T.; Miyazono, K. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res. 2009, 19, 103-115.
6. Erlebacher, A.; Price, K. A.; Glimcher, L. H. Maintenance of mouse trophoblast stem cell proliferation by TGF-beta/activin. Dev. Biol. 2004, 275, 158-169.
7. Shi, Y.; Massague, J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113, 685-700.
8. Piek, E.; Heldin, C. H.; ten Dijke, P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 1999, 13, 2105-2124.
9. Zhang, Y. E. Non-Smad pathways in TGF-beta signaling. Cell Res. 2009, 19, 128-139.
10. Lee, M. K.; Pardoux, C.; Hall, M. C.; Lee, P. S.; Warburton, D.; Qing, J.; Smith, S. M.; Derynck, R. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 2007, 26, 3957-3967.
11. Hayashida, T.; Decaestecker, M.; Schnaper, H. W. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J. 2003, 17, 1576-1578.
12. Conery, A. R.; Cao, Y.; Thompson, E. A.; Townsend, C. M., Jr.; Ko, T. C.; Luo, K. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. Nat. Cell Biol. 2004, 6, 366-372.
13. Remy, I.; Montmarquette, A.; Michnick, S. W. PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat. Cell Biol. 2004, 6, 358-365.
14. Kato, M.; Putta, S.; Wang, M.; Yuan, H.; Lanting, L.; Nair, I.; Gunn, A.; Nakagawa, Y.; Shimano, H.; Todorov, I.; et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 2009, 11, 881-889.
15. Lamouille, S.; Derynck, R. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J. Cell Biol. 2007, 178, 437-451.
16. Wang, Z.; Song, Y.; Tu, W.; He, X.; Lin, J.; Liu, F. Beta-2 spectrin is involved in hepatocyte proliferation through the interaction of TGFbeta/Smad and PI3K/AKT signalling. Liver Int. 2012, 32, 1103-1111.
17. Lei, X.; Bandyopadhyay, A.; Le, T.; Sun, L. Autocrine TGFbeta supports growth and survival of human breast cancer MDA-MB-231 cells. Oncogene 2002, 21, 7514-7523.
18. Derynck, R.; Akhurst, R. J.; Balmain, A. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 2001, 29, 117-129.
19. Holland, J. D.; Klaus, A.; Garratt, A. N.; Birchmeier, W. Wnt signaling in stem and cancer stem cells. Curr. Opin. Cell Biol. 2013, 25, 254-264.
20. Kim, W.; Kim, M.; Jho, E. H. Wnt/beta-catenin signalling: From plasma membrane to nucleus. Biochem. J. 2013, 450, 9-21.
21. King, T. D.; Suto, M. J.; Li, Y. The Wnt/beta-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer. J. Cell. Biochem. 2012, 113, 13-18.
22. MacDonald, B. T.; Tamai, K.; He, X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17, 9-26.
23. Aberle, H.; Bauer, A.; Stappert, J.; Kispert, A.; Kemler, R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997, 16, 3797-3804.
24. Kypta, R. M.; Waxman, J. Wnt/beta-catenin signalling in prostate cancer. Nat. Rev. Urol. 2012, 9, 418-428.
25. Fagotto, F. Looking beyond the Wnt pathway for the deep nature of beta-catenin. EMBO Rep. 2013, 14, 422-433.
26. Webster, M. R.; Weeraratna, A. T. A Wnt-er migration: The confusing role of beta-catenin in melanoma metastasis. Sci. Signal. 2013, doi: 10. 1126/scisignal. 2004114.
27. Behrens, J.; Jerchow, B. A.; Wurtele, M.; Grimm, J.; Asbrand, C.; Wirtz, R.; Kuhl, M.; Wedlich, D.; Birchmeier, W. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998, 280, 596-599.
28. Behrens, J.; von Kries, J. P.; Kuhl, M.; Bruhn, L.; Wedlich, D.; Grosschedl, R.; Birchmeier, W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996, 382, 638-642.
29. Shtutman, M.; Zhurinsky, J.; Simcha, I.; Albanese, C.; D'Amico, M.; Pestell, R.; Ben-Ze'ev, A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 1999, 96, 5522-5527.
30. Tetsu, O.; McCormick, F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398, 422-426.
31. He, T. C.; Sparks, A. B.; Rago, C.; Hermeking, H.; Zawel, L.; da Costa, L. T.; Morin, P. J.; Vogelstein, B.; Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science 1998, 281, 1509-1512.
32. Gadue, P.; Huber, T. L.; Paddison, P. J.; Keller, G. M. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc. Natl. Acad. Sci. USA 2006, 103, 16806-16811.
33. Jian, H.; Shen, X.; Liu, I.; Semenov, M.; He, X.; Wang, X. F. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev. 2006, 20, 666-674.
34. Moon, R. T.; Kohn, A. D.; de Ferrari, G. V.; Kaykas, A. WNT and beta-catenin signalling: Diseases and therapies. Nat. Rev. Genet. 2004, 5, 691-701.
35. Mosimann, C.; Hausmann, G.; Basler, K. Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat. Rev. Mol. Cell Biol. 2009, 10, 276-286.
36. Gills, J. J.; Dennis, P. A. Perifosine: Update on a novel Akt inhibitor. Curr. Oncol. Rep. 2009, 11, 102-110.
37. Hirai, H.; Sootome, H.; Nakatsuru, Y.; Miyama, K.; Taguchi, S.; Tsujioka, K.; Ueno, Y.; Hatch, H.; Majumder, P. K.; Pan, B. S.; et al. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol. Cancer Ther. 2010, 9, 1956-1967.
38. Inoki, K.; Ouyang, H.; Zhu, T.; Lindvall, C.; Wang, Y.; Zhang, X.; Yang, Q.; Bennett, C.; Harada, Y.; Stankunas, K.; et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006, 126, 955-968.
39. Mao, J.; Fan, S.; Ma, W.; Fan, P.; Wang, B.; Zhang, J.; Wang, H.; Tang, B.; Zhang, Q.; Yu, X.; et al. Roles of Wnt/beta-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis. 2014, doi: 10. 1038/cddis. 2013. 515.
40. Ji, D.; Zhang, Z.; Cheng, L.; Chang, J.; Wang, S.; Zheng, B.; Zheng, R.; Sun, Z.; Wang, C.; Liu, R.; et al. The Combination of RAD001 and MK-2206 exerts synergistic cytotoxic effects against PTEN mutant gastric cancer cells: Involvement of MAPK-dependent autophagic, but not apoptotic cell death pathway. PLoS One 2014, 9, e85116.
41. Yap, T. A.; Yan, L.; Patnaik, A.; Fearen, I.; Olmos, D.; Papadopoulos, K.; Baird, R. D.; Delgado, L.; Taylor, A.; Lupinacci, L.; et al. First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors. J. Clin. Oncol. 2011, 29, 4688-4695.
42. Yu, Z.; Wang, C.; Wang, M.; Li, Z.; Casimiro, M. C.; Liu, M.; Wu, K.; Whittle, J.; Ju, X.; Hyslop, T.; et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell Biol. 2008, 182, 509-517.
43. Esteban, M. A.; Xu, J.; Yang, J.; Peng, M.; Qin, D.; Li, W.; Jiang, Z.; Chen, J.; Deng, K.; Zhong, M.; et al. Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J. Biol. Chem. 2009, 284, 17634-17640.